In a filing, Rhythm Pharmaceuticals Inc revealed its Chief Technical Officer Shulman Joseph unloaded Company’s shares for reported $0.42 million on Aug 21 ’25. In the deal valued at $100.07 per share,4,188 shares were sold. As a result of this transaction, Shulman Joseph now holds 8,509 shares worth roughly $0.84 million.
Then, JOSEPH SHULMAN bought 4,188 shares, generating $413,356 in total proceeds.
Before that, Smith Hunter C sold 24,611 shares. Rhythm Pharmaceuticals Inc shares valued at $2,370,832 were divested by the Chief Financial Officer at a price of $96.33 per share. As a result of the transaction, Smith Hunter C now holds 116,915 shares, worth roughly $11.6 million.
Goldman initiated its Rhythm Pharmaceuticals Inc [RYTM] rating to a Buy in a research note published on July 10, 2025; the price target was $97. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who began to cover the stock in early July with a ‘”an Outperform”‘ rating. BofA Securities also remained covering RYTM and has increased its forecast on April 07, 2025 with a “Buy” recommendation from previously “Neutral” rating.
Price Performance Review of RYTM
On Monday, Rhythm Pharmaceuticals Inc [NASDAQ:RYTM] saw its stock fall -3.94% to $99.2. Over the last five days, the stock has gained 1.13%. Rhythm Pharmaceuticals Inc shares have risen nearly 118.60% since the year began. Nevertheless, the stocks have risen 77.21% over the past one year. While a 52-week high of $104.87 was reached on 08/22/25, a 52-week low of $44.31 was recorded on 04/07/25.
Levels Of Support And Resistance For RYTM Stock
The 24-hour chart illustrates a support level at 97.64, which if violated will result in even more drops to 96.07. On the upside, there is a resistance level at 101.76. A further resistance level may holdings at 104.31.
How much short interest is there in Rhythm Pharmaceuticals Inc?
A steep rise in short interest was recorded in Rhythm Pharmaceuticals Inc stocks on 2025-07-31, dropping by -0.34 million shares to a total of 4.51 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 4.85 million shares. There was a decline of -7.52%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on January 02, 2025 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $80 price target.
